![]() |
首页 > 美迪医讯 > Abbott公司即将研制先兆子痫检测方法 |
Abbott公司即将研制先兆子痫检测方法 【 2005-08-04 发布 】 美迪医讯
根据一项近期的协议,Abbott实验室获得了将Nephromics公司获得的的检测和监测先兆子痫的两种蛋白质,开发成商业化产品的全球准独家权利。, Abbott打算开发成为检测先兆子痫的体外检测方法。目前对这种危及生命的疾病还没有特异性的诊断检测方法,这种疾病每年都危及许多妊娠妇女。Abbott实验室诊断测试与系统开发副总裁William Brow博士解释说:“Abbott的目标是开发分娩前检测方法,能够用于对妊娠并发症进行早期的危险分层检测。” Abbott具有研发内分泌和其它激素相关检测方法的历史;向全球诊断检测市场的关键领域提供范围广泛的革新设备系统和检测方法。
Abbott to Develop Preeclampsia Test Abbott intends to develop an in vitro diagnostic test to detect preeclampsia. There is currently no specific diagnostic test for this life-threatening disease that affects many pregnant women each year. “Abbott’s goal is to develop prenatal tests that could be utilized for early risk stratification of pregnancy complications,” explained William Brown, Ph.D., vice president, diagnostic assays and systems development, Abbott Labs. Abbott has a history of developing endocrine and other hormone-related tests and offers a broad range of innovative instrument systems and tests across key segments of the global diagnostics market. Immunodiagnostics is a core component of the company’s medical products business. “Because preeclampsia can strike quickly, potentially causing severe and immediate complications such as seizures and organ failure that threaten both the health of the baby and mother unless pregnancy is induced, early diagnostic tests are needed,” observed David Barch, M.D., medical director, Abbott Diagnostics. “These tests would be developed for use on our premier diagnostic analyzer, the Architect integrated immunoassay and clinical chemistry system.” 本文关键字:
Abbott公司,先兆子痫
《美迪医讯》欢迎您参与新闻投稿,业务咨询: 美迪医疗网业务咨询更多关于 Abbott公司,先兆子痫 的新闻《上海医疗器械批发》产品推荐
|
合作支持:中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会 |
刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图 |
把美迪网放进收藏夹 把美迪医疗网介绍给我的朋友 给美迪医疗网留言
美迪医疗网广告业务联系:021-51601230 产品咨询业务联系:021-51601230 传真:021-56532303 ![]() 互联网药品信息服务许可证:(沪)-经营性-2009-0003 中华人民共和国电信与信息服务业务经营许可证:(沪)B2-20090029 ![]() ![]() ![]() 公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号 营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081 |